HopeStage
Back to all studies
CompletedNCT02556060

Lamotrigine for Ketamine Dependence

About this titleRead the official source — NCT02556060
Medication studyAges 18–65TaiwanAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
TaipeiSee all locations and recruitment
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2015
Recruitment status
Completed
Enrollment listed in the registry
30
Sponsor
Taipei City Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
Taiwan
Age range
From 18 Years to 65 Years
Official registry ID
NCT02556060
Official title
Show the full official title

Lamotrigine for Ketamine Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Taipei

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Taipei City Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including lamotrigine and Placebo.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies